{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:27:55Z","timestamp":1793834875381,"version":"4.6.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Glioma is the most malignant cancer in the brain. As a major vitamin-K-dependent protein in the central nervous system, PROS1 not only plays a vital role in blood coagulation, and some studies have found that it was associated with tumor immune infiltration. However, the prognostic significance of PROS1 in glioma and the underlying mechanism of PROS1 in shaping the tumor immune microenvironment (TIME) remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The raw data (including RNA-seq, sgRNA-seq, clinicopathological variables and prognosis, and survival data) were acquired from public databases, including TCGA, GEPIA, CGGA, TIMER, GEO, UALCAN, and CancerSEA. GO enrichment and KEGG pathway analyses were performed using \u201ccluster profiler\u201d package and visualized by the \u201cggplot2\u201d package. GSEA was conducted using R package \u201ccluster profiler\u201d. Tumor immune estimation resource (TIMER) and spearman correlation analysis were applied to evaluate the associations between infiltration levels of immune cells and the expression of PROS1. qRT-PCR and WB were used to assay the expression of PROS1. Wound-healing assay, transwell chambers assays, and CCK-8 assays, were performed to assess migration and proliferation. ROC and KM curves were constructed to determine prognostic significance of PROS1 in glioma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The level of PROS1 expression was significantly increased in glioma in comparison to normal tissue, which was further certificated by qRT-PCR and WB in LN-229 and U-87MG glioma cells. High expression of PROS1 positively correlated with inflammation, EMT, and invasion identified by CancerSEA, which was also proved by downregulation of PROS1 could suppress cells migration, and proliferation in LN-229 and U-87MG glioma cells. GO and KEGG analysis suggested that PROS1 was involved in disease of immune system and T cell antigen receptor pathway. Immune cell infiltration analysis showed that expression of PROS1 was negatively associated with pDC and NK CD56 bright cells while positively correlated with Macrophages, Neutrophils in glioma. Immune and stromal scores analysis indicated that PROS1 was positively associated with immune score. The high level of PROS1 resulted in an immune suppressive TIME <jats:italic>via<\/jats:italic> the recruitment of immunosuppressive molecules. In addition, Increased expression of PROS1 was correlated with T-cell exhaustion, M2 polarization, poor Overall-Survival (OS) in glioma. And it was significantly related to tumor histological level, age, primary therapy outcome. The results of our experiment and various bioinformatics approaches validated that PROS1 was a valuable poor prognostic marker.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Increased expression of PROS1 was correlated with malignant phenotype and associated with poor prognosis in glioma. Besides, PROS1 could be a possible biomarker and potential immunotherapeutic target through promoting the glioma immunosuppressive microenvironment and inducing tumor-associated macrophages M2 polarization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1052692","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:14:07Z","timestamp":1672841647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma"],"prefix":"10.3389","volume":"13","author":[{"given":"Jinxiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenle","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengliang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: A \"state of the science\" review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0052","article-title":"Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Nabors","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.08.114","article-title":"Persistent disparities in survival for patients with glioblastoma","volume":"120","author":"Fatehi","year":"2018","journal-title":"World Neurosurg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.12.003","article-title":"Immunotherapy for malignant glioma: Current status and future directions","volume":"41","author":"Wang","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02593-w","article-title":"Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer","volume":"69","author":"Saleh","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024947","article-title":"Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas","volume":"384","author":"Friedman","year":"2021","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01281","article-title":"Identification of immune-related genes contributing to the development of glioblastoma using weighted gene Co-expression network analysis","volume":"11","author":"Kong","year":"2020","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.569020","article-title":"Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation","volume":"289","author":"Tsou","year":"2014","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112103","article-title":"TAM receptor signaling in immune homeostasis","volume":"33","author":"Rothlin","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ni871","article-title":"Serum-derived protein s binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells","volume":"4","author":"Anderson","year":"2003","journal-title":"Nat Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017030234","article-title":"Protein s protects against podocyte injury in diabetic nephropathy","volume":"29","author":"Zhong","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14183","article-title":"The Pros1\/Tyro3 axis protects against periodontitis by modulating STAT\/SOCS signalling","volume":"23","author":"Jiang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2433","article-title":"Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma","volume":"78","author":"Sadahiro","year":"2018","journal-title":"Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97354","article-title":"Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response","volume":"128","author":"Ubil","year":"2018","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126089","article-title":"Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10","volume":"131","author":"Maimon","year":"2021","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121843","article-title":"(ProS1) activates a Tyro3-erk signalling axis and protects cancer cells from apoptosis","volume":"11","author":"Al Kafri","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14753","article-title":"Protein s drives oral squamous cell carcinoma tumorigenicity through regulation of AXL","volume":"8","author":"Abboud-Jarrous","year":"2017","journal-title":"Oncotarget"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.384438","article-title":"Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein s during the development of high grade and castration-resistant prostate cancer","volume":"287","author":"Saraon","year":"2012","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese Glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genomics Proteomics Bioinf"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bti270","article-title":"Use of within-array replicate spots for assessing differential expression in microarray experiments","volume":"21","author":"Smyth","year":"2005","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An r package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: A web server for gene set cancer analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.11.026","article-title":"Identification and validation of potential target genes in papillary thyroid cancer","volume":"843","author":"Zhang","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1530\/ERC-16-0126","article-title":"Role of protein s in castration-resistant prostate cancer-like cells","volume":"23","author":"Ning","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3703","article-title":"Treatment of patients with relapsed or refractory mantle-cell lymphoma with zanubrutinib, a selective inhibitor of bruton's tyrosine kinase","volume":"26","author":"Song","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2010.03.031","article-title":"CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival","volume":"17","author":"Yang","year":"2010","journal-title":"J Clin Neurosci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2563","article-title":"Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy","volume":"17","author":"Prins","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nature12998","article-title":"The E3 ligase cbl-b and TAM receptors regulate cancer metastasis via natural killer cells","volume":"507","author":"Paolino","year":"2014","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.06.010","article-title":"T Cell-derived protein s engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response","volume":"39","author":"Carrera Silva","year":"2013","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/glia.21136","article-title":"The brain tumor microenvironment","volume":"59","author":"Charles","year":"2011","journal-title":"Glia"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153678","article-title":"BAP1 loss promotes suppressive tumor immune microenvironment via upregulation of PROS1 in class 2 uveal melanomas","volume":"14","author":"Kaler","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124184","article-title":"Sitravatinib potentiates immune checkpoint blockade in refractory cancer models","volume":"14","author":"Du","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.564133","article-title":"Expression of TAM-r in human immune cells and unique regulatory function of MerTK in IL-10 production by tolerogenic DC","volume":"11","author":"Giroud","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1039\/c7sc04853j","article-title":"Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy","volume":"9","author":"Zhao","year":"2018","journal-title":"Chem Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701302","article-title":"A believer's overview of cancer immunosurveillance and immunotherapy","volume":"200","author":"Finn","year":"2018","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-4110","article-title":"Anti-PD-1 induces M1 polarization in the glioma microenvironment and exerts therapeutic efficacy in the absence of CD8 cytotoxic T cells","volume":"26","author":"Rao","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/srep26662","article-title":"Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in behcet's disease","volume":"6","author":"Qin","year":"2016","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00256","article-title":"Immunotherapy of malignant tumors in the brain: How different from other sites","volume":"6","author":"Dutoit","year":"2016","journal-title":"Front Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12967-022-03536-y","article-title":"LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification","volume":"20","author":"Zhou","year":"2022","journal-title":"J Transl Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox054","article-title":"Correlation of immune phenotype with IDH mutation in diffuse glioma","volume":"19","author":"Berghoff","year":"2017","journal-title":"Neuro Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31442-3","article-title":"Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p\/19q non-co-deleted anaplastic glioma: A phase 3, randomised, open-label intergroup study","volume":"390","author":"van den Bent","year":"2017","journal-title":"Lancet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1052692\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:14:10Z","timestamp":1672841650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1052692\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2022.1052692"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1052692","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1052692"}}